Skip to main content
Signal8

Dunne Michael W.

SEC insider (Form 3/4/5 filer). CIK 0001553593. Director at Iterum Therapeutics plc (ITRM). 2 reported Form 4/5 transactions since Sep 2024; latest on Nov 18, 2025. Located in DUBLIN 1, L2.

Companies Dunne Michael W. has filed insider reports for

  • Iterum Therapeutics plc (ITRM): Director
Dunne Michael W. profile photo

Dunne Michael W.

CIK: 0001553593

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Iterum Therapeutics plc logo
ITRM

Iterum Therapeutics plc

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Iterum Therapeutics plc logo
    ITRM

    Iterum Therapeutics plc

    Nov 18, 2025
    Purchase
    Direct
    6K shares at avg. $0.37$2K
  • Iterum Therapeutics plc logo
    ITRM

    Iterum Therapeutics plc

    Aug 8, 2025
    Purchase
    Direct
    15K shares at avg. $0.72$11K

1-2 of 2